Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy

Cell Reports Medicine(2023)10.1016/j.xcrm.2022.100896Source: DataRank Database

Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy is a research paper published in Cell Reports Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.29)OA: goldTopics (45)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Ashraf Ul Kabir ORCID,Derek A. G. Barisas ORCID,Karen Krchma ORCID,Kyunghee Choi ORCID,Madhav Subramanian ORCID

Live enrichment

PubMed:36630952 OpenAlex:https://openalex.org/W4315474709

NHLBI

Grant: R01HL149954

NHLBI

Grant: R01HL55337

National Institutes of Health

Grant: 5R01HL055337-23

HEMANGIOBLAST DEVELOPMENT AND REGULATION

National Institutes of Health

Grant: 5T32AI007163-42

Training Program in Immunology

National Institutes of Health

Grant: 5R01HL149954-04

Epigenetic regulations of macrophage development

NHLBI NIH HHS

Grant: R01 HL055337

NHLBI NIH HHS

Grant: R01 HL063736

FWCI

3.29

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S266637912200475X/pdf

publisherhttp://www.cell.com/article/S266637912200475X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S266637912200475X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S266637912200475X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.xcrm.2022.100896

Fields of Study

Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentFerroptosis and cancer prognosis0301 basic medicine0303 health sciences03 medical and health sciencesHumansImmune Checkpoint InhibitorsTumor MicroenvironmentCarcinoma, Renal CellTranscriptomeKidney Neoplasms

MeSH Terms

Immune Checkpoint InhibitorsCarcinoma, Renal CellHumansKidney NeoplasmsTumor MicroenvironmentTranscriptome

Keywords

Immune checkpointTumor microenvironmentBlockadeImmune systemAngiogenesisImmunotherapyMedicineOncologyCancerInternal medicineImmunologyCancer researchReceptorCarcinomaICTS (Institute of Clinical and Translational Sciences)Renal CellArticleKidney Neoplasms616Medicine and Health SciencesHumansTranscriptomeImmune Checkpoint InhibitorsCarcinoma, Renal Cellimmune checkpoint blockadetumor angiogenesistumor immunity

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being